Pharmaceuticals, Biotechnology and Life Sciences
BOSTON, Aug. 05, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing…
BOTHELL, Wash., Aug. 05, 2021 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on…
MALVERN, Pa., Aug. 05, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,…
Jiuquan, China, Aug. 05, 2021 (GLOBE NEWSWIRE) — Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical…
• Preliminary translational data validate UCARTCS1 as a promising potential therapy for relapsed orrefractory multiple myeloma patients. • Preclinical pipeline disclosed at…
ROCKVILLE, Aug. 05, 2021 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative…
NEW YORK, Aug. 05, 2021 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology…
Raises full year 2021 guidance and announces deal to acquire Pinnacle 21PRINCETON, N.J., Aug. 05, 2021 (GLOBE NEWSWIRE) — Certara,…
BUFFALO, N.Y., Aug. 05, 2021 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company…
Transaction expected to be accretive to Certara’s revenue, revenue growth and adjusted EBITDA marginPRINCETON, N.J., Aug. 05, 2021 (GLOBE NEWSWIRE)…